164 related articles for article (PubMed ID: 9720839)
1. Relationship between apolipoprotein E polymorphism, menopausal symptoms, and serum lipids during hormone replacement therapy.
Somekawa Y; Wakabayashi A
Eur J Obstet Gynecol Reprod Biol; 1998 Aug; 79(2):185-91. PubMed ID: 9720839
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
Cubrilo-Turek M; Sertić J; Duraković Z
Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
[TBL] [Abstract][Full Text] [Related]
3. The influence of apo E phenotypes on the plasma triglycerides response to hormonal replacement therapy during the menopause.
Tolosa M; Peiró S; Real JT; Cano A; Ascaso JF; Carmena R
Maturitas; 2001 Nov; 40(2):173-81. PubMed ID: 11716996
[TBL] [Abstract][Full Text] [Related]
4. Influence of apolipoprotein E polymorphism on the tracking of childhood levels of serum lipids and apolipoproteins over a 6-year period. The Bogalusa Heart Study.
Srinivasan SR; Ehnholm C; Wattigney WA; Berenson GS
Atherosclerosis; 1996 Nov; 127(1):73-9. PubMed ID: 9006807
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E phenotype associations with plasma lipoproteins and bone mass in postmenopausal women.
Sanada M; Nakagawa H; Kodama I; Sakasita T; Ohama K
Climacteric; 1998 Sep; 1(3):188-95. PubMed ID: 11907943
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E genotype and response of lipid levels to postmenopausal estrogen use.
von Muhlen D; Barrett-Connor E; Kritz-Silverstein D
Atherosclerosis; 2002 Mar; 161(1):209-14. PubMed ID: 11882334
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E polymorphism in diabetic and non-diabetic patients: does it really contribute to atherosclerosis?
Camsari A; Tamer L; Aras Ateş N; Pekdemir H; Ciçek D; Ercan B; Camdeviren H; Atik U
Acta Cardiol; 2005 Aug; 60(4):409-14. PubMed ID: 16128374
[TBL] [Abstract][Full Text] [Related]
8. Estrogen replacement therapy, serum lipids, and polymorphism of the apolipoprotein E gene.
Garry PJ; Baumgartner RN; Brodie SG; Montoya GD; Liang HC; Lindeman RD; Williams TM
Clin Chem; 1999 Aug; 45(8 Pt 1):1214-23. PubMed ID: 10430787
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E phenotype affects the malondialdehyde-modified LDL concentration and forearm endothelial function in postmenopausal women.
Tsuda M; Sanada M; Higashi Y; Hara Y; Kodama I; Chayama K; Yoshizumi M; Ohama K
Clin Endocrinol (Oxf); 2004 Nov; 61(5):619-25. PubMed ID: 15521966
[TBL] [Abstract][Full Text] [Related]
10. Phenotype of apolipoprotein E influences the lipid metabolic response of postmenopausal women to hormone replacement therapy.
Tsuda M; Sanada M; Nakagawa H; Kodama I; Sakashita T; Ohama K
Maturitas; 2001 May; 38(3):297-304. PubMed ID: 11358647
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal effects of apolipoprotein E alleles (epsilon 2 and epsilon 4) on plasma lipid levels in normolipidemic subjects.
Eto M; Watanabe K; Ishii K
Clin Genet; 1986 Jun; 29(6):477-84. PubMed ID: 3461894
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic effects of apolipoprotein structural variation on lipid profiles. III. Contribution of apolipoprotein E phenotype to prediction of total cholesterol, apolipoprotein B, and low density lipoprotein cholesterol in the healthy women study.
Eichner JE; Kuller LH; Ferrell RE; Meilahn EN; Kamboh MI
Arteriosclerosis; 1990; 10(3):379-85. PubMed ID: 2344296
[TBL] [Abstract][Full Text] [Related]
13. Influence of apolipoprotein E polymorphism on bezafibrate treatment response in dyslipidemic patients.
Yamada M
J Atheroscler Thromb; 1997; 4(1):40-4. PubMed ID: 9583353
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4.
Muros M; Rodríguez-Ferrer C
Atherosclerosis; 1996 Mar; 121(1):13-21. PubMed ID: 8678918
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between gene polymorphism at the apolipoprotein E locus and serum lipid profile in urban children of school age in Beijing].
Zhu W; Feng N; Wang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Sep; 35(5):297-300. PubMed ID: 11769625
[TBL] [Abstract][Full Text] [Related]
16. Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan.
Kobori S; Nakamura N; Uzawa H; Shichiri M
Atherosclerosis; 1988 Jan; 69(1):81-8. PubMed ID: 3355609
[TBL] [Abstract][Full Text] [Related]
17. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.
Somekawa Y; Umeki H; Kobayashi K; Tomura S; Aso T; Hamaguchi H
J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes. The Strong Heart Study.
Kataoka S; Robbins DC; Cowan LD; Go O; Yeh JL; Devereux RB; Fabsitz RR; Lee ET; Welty TK; Howard BV
Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):918-25. PubMed ID: 8696954
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E polymorphism modulates the association between obesity and dyslipidemias during young adulthood: The Bogalusa Heart Study.
Srinivasan SR; Ehnholm C; Elkasabany A; Berenson GS
Metabolism; 2001 Jun; 50(6):696-702. PubMed ID: 11398147
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E gene polymorphism alters lipids before pancreas transplantation.
Balakrishnan S; Colling C; Burkman T; Erickson J; Lyden E; Maheshwari H; Mack-Shipman L; Lane J; Larsen J
Transplantation; 2002 Oct; 74(7):974-7. PubMed ID: 12394840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
